Kaneke supplies raw materials to Fujifilm to increase production of Avigan
On April 16, in response to the new crown epidemic, Minoru Tanaka, President of Osaka International Chemical Manufacturing Company Kaneke, has reached an agreement with Kenji Sukeno, President of Fujifilm Japan, and decided to supply Fujifilm with the production of the anti-influenza drug Avigan® tablets (generic drug name: Fapiravir) required API.
As the new crown epidemic continues to spread, the Japanese government has decided to expand Avigan's hoarding to 2 million people because of its potential to effectively combat the new crown virus. Prior to this, Fujifilm has expanded its production system to increase production of Avigi.
Kaneke said that the company is required to provide Avigan's APIs as a major supplier. It will invest capital, mobilize personnel, and adjust production plans to urgently improve the manufacturing system and start supplying related drugs in July.
2026-10-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Fujifilm to Invest €25 Million in Semiconductor Material Production Capacity in Belgium
-
Fujifilm invested in the construction of a cell culture medium production base
-
BASF Partners with Sinopec to Accelerate Application of Biomethane at Nanjing
-
Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical Agree in Principle to Establish New Joint Venture to Restructure Ethylene Production in Western Japan
-
Wanhua Chemical's Fujian 800,000 t/y MDI Plant Undergoes Scheduled Maintenance
-
“Europe’s Chemical Industry Is Bleeding”: 37 Million Tons of Capacity Shut Down in 4 Years—Is the Industrial Heartbeat Failing?
-
5%–10% Is Just the Surface: Behind Dow’s Greater China Price Letter Lies a Global Repricing of Silicones
-
“Amputate to Survive, or Bleed to Feed the Vultures?”: Dow’s 4,500 Layoffs Reveal the Life-or-Death Battle in Global Chemicals
-
“Hidden Champion” Swallowed Whole: PPG’s Acquisition of EMM Isn’t Just About Three Brands—It’s a Grab for the Next Decade’s Coating Authority
-
Kuraray Exits China’s PMMA Market, with Jiangsu Shuangxiang Group Taking Over
Recommend Reading
-
BASF and Encina Bet on Circular Chemical Feedstocks
-
Novo Nordisk Sounds the Alarm: Growth Headwinds Loom Over Global Operations in 2026
-
Brenntag Expands Distribution of Givaudan’s Active Beauty Ingredients to Malaysia and Singapore
-
When the Chemical Industry Is No Longer Highly Profitable: Sinochem International’s 2.4 Billion Yuan Loss Reveals the Truth About Industry Cycles
-
Wanhua Chemical Establishes a RMB 1.488 Billion New Energy Materials Company in Weifang, Further Integrating Green Power and Battery Materials Businesses
-
Supply Pressure Remains, Adipic Acid Prices Continue to Decline
-
Methanol Market Conditions Consolidate and Operate
-
Industry inventory accumulation pushes acrylonitrile prices to five-year low in China
-
Inventory Pressure Concentrated Release, Lithium Carbonate Plunges 18%
-
Trend Slowing Down! Melamine Enters a Volatile Bottoming-Out Cycle